InvestSMART

Anteris Technologies Ltd (ASX: AVR) - Announcements

Current share price for AVR : $11.700 0.15 (1.30%)+

ASX company news and announcements for Anteris Technologies Ltd (AVR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anteris Technologies Ltd (AVR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anteris Technologies Ltd (AVR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anteris Technologies Ltd (AVR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$178 Notification of cessation of securities - AVR 7 Apr 2025 1:00PM $5.400 $11.700 risen by 116.67%
$178 Statement of CDIs on issue - AVR 2 Apr 2025 3:17PM $5.700 $11.700 risen by 105.26%
$178 Clinical Milestone - 100 patients treated with DurAVR THV 31 Mar 2025 9:26AM $7.420 $11.700 risen by 57.68%
$178 Cleansing Notice 27 Mar 2025 6:54PM $7.650 $11.700 risen by 52.94%
$178 Application for quotation of securities - AVR 27 Mar 2025 6:49PM $7.650 $11.700 risen by 52.94%
$178 Notification regarding unquoted securities - AVR 27 Mar 2025 6:41PM $7.650 $11.700 risen by 52.94%
$178 Change of Directors' Interest Notice 21 Mar 2025 10:20AM $9.920 $11.700 risen by 17.94%
$178 Anteris Reports One-Year Patient Outcomes for DurAVR THV 21 Mar 2025 9:33AM $9.930 $11.700 risen by 17.82%
$178 Corporate Governance Statement and Appendix 4G 13 Mar 2025 8:54AM $11.070 $11.700 risen by 5.69%
$178 2024 Financial Results and Corporate Update 13 Mar 2025 8:50AM $11.070 $11.700 risen by 5.69%
$178 Annual Report to shareholders 13 Mar 2025 8:47AM $11.070 $11.700 risen by 5.69%
$178 Cleansing Notice 11 Mar 2025 5:01PM $11.000 $11.700 risen by 6.36%
$178 Initial Director's Interest Notice 7 Mar 2025 1:31PM $11.960 $11.700 fallen by 2.17%
$178 Director Appointment/Resignation 6 Mar 2025 5:44PM $12.000 $11.700 fallen by 2.50%
$178 Statement of CDIs on issue - AVR 5 Mar 2025 7:10PM $11.265 $11.700 risen by 3.86%
$178 Application for quotation of securities - AVR 5 Mar 2025 7:09PM $11.265 $11.700 risen by 3.86%
$178 ASX waiver from requirement to lodge an Appendix 4E 28 Feb 2025 9:51AM $11.200 $11.700 risen by 4.46%
$178 Notification of cessation of securities - AVR 18 Feb 2025 4:34PM $12.000 $11.700 fallen by 2.50%
$178 Release of Australian Taxation Office Class Rulings 13 Feb 2025 5:40PM $13.040 $11.700 fallen by 10.28%
$178 Application for quotation of securities - AVR 12 Feb 2025 2:39PM $12.730 $11.700 fallen by 8.09%
$178 Statement of CDIs on issue - AVR 3 Feb 2025 6:51PM $9.990 $11.700 risen by 17.12%
$178 Cleansing Notice 16 Jan 2025 5:36PM $9.250 $11.700 risen by 26.49%
$178 Partial Exercise of Option and End of Stabilisation Period 15 Jan 2025 9:43AM $9.500 $11.700 risen by 23.16%
$178 Daily Stabilisation Activity Report - 10 January 2025 13 Jan 2025 9:35AM $9.200 $11.700 risen by 27.17%
$178 Daily Stabilisation Activity Report - 8 January 2025 9 Jan 2025 9:45AM $9.490 $11.700 risen by 23.29%

126 - 150 of 695 results

Page 6 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.